The global conversation surrounding psilocybin has shifted dramatically in 2026. As clinical research progresses toward potential FDA evaluation and legislative frameworks evolve in regions like the United States, Australia, and the Czech Republic, the distinction between medical-grade therapy and consumer-market products has never been more important. For those seeking to understand the science, legal landscape, […]